Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol

被引:3
|
作者
Marrero, Natalie [1 ]
Jha, Kunal [2 ,10 ]
Razavi, Alexander C. [2 ,3 ]
Boakye, Ellen [2 ]
Anchouche, Khalil [4 ,5 ]
Dzaye, Omar [2 ]
Budoff, Matthew J. [2 ]
Tsai, Michael Y. [8 ]
Shah, Sanjiv J. [9 ]
Rotter, Jerome I. [7 ]
Guo, Xiuqing [7 ]
Yao, Jie [7 ]
Blumenthal, Roger S. [2 ]
Thanassoulis, George [4 ,5 ]
Post, Wendy S. [2 ]
Blaha, Michael J. [6 ]
Whelton, Seamus P. [2 ]
机构
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Dis, 600 N Wolfe St,Blalock 524A, Baltimore, MD 21287 USA
[3] Emory Sch Med, Ctr Heart Dis Prevent, Atlanta, GA USA
[4] McGill Univ, Dept Med, Prevent & Genom Cardiol, Montreal, PQ, Canada
[5] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada
[6] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Med, Torrance, CA USA
[7] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Lundquist Inst Biomed Innovat, Dept Pediat, Torrance, CA USA
[8] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA
[9] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL USA
[10] Univ Louisville, Div Cardiol, Louisville, KY USA
关键词
aortic valve stenosis; aortic stenosis; computed tomography; lipoprotein(a); lipoproteins; LDL; X-ray; CORONARY-ARTERY CALCIUM; VALVULAR CALCIFICATION; OXIDIZED PHOSPHOLIPIDS; NATURAL-HISTORY; PROGRESSION; DISEASE; ASSOCIATION; ATHEROSCLEROSIS; INFLAMMATION; METAANALYSIS;
D O I
10.1161/CIRCIMAGING.123.016372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Aortic valve calcification (AVC), Lp(a) [lipoprotein(a)], and low-density lipoprotein cholesterol (LDL-C) are associated with severe aortic stenosis (AS). We aimed to determine which of these risk factors were most strongly associated with the risk of incident severe AS. METHODS: A total of 6792 participants from the MESA study (Multi-Ethnic Study of Atherosclerosis) had computed tomography-quantified AVC, Lp(a), and LDL-C values at MESA visit 1 (2000-2002). We calculated the absolute event rate of incident adjudicated severe AS per 1000 person-years and performed multivariable adjusted Cox proportional hazards regression. RESULTS: The mean age was 62 years old, and 47% were women. Over a median 16.7-year follow-up, the rate of incident severe AS increased exponentially with higher AVC, regardless of Lp(a) or LDL-C values. Participants with AVC=0 had a very low rate of severe AS even with elevated Lp(a) >= 50 mg/dL (<0.1/1000 person-years) or LDL-C >= 130 mg/dL (0.1/1000 person-years). AVC >0 was strongly associated with severe AS when Lp(a) <50 mg/dL hazard ratio (HR) of 33.8 (95% CI, 16.4-70.0) or >= 50 mg/dL HR of 61.5 (95% CI, 7.7-494.2) and when LDL-C <130 mg/dL HR of 31.1 (95% CI, 14.4-67.1) or >= 130 mg/dL HR of 50.2 (95% CI, 13.2-191.9). CONCLUSIONS: AVC better identifies people at high risk for severe AS compared with Lp(a) or LDL-C, and people with AVC=0 have a very low long-term rate of severe AS regardless of Lp(a) or LDL-C level. These results suggest AVC should be the preferred prognostic risk marker to identify patients at high risk for severe AS, which may help inform participant selection for future trials testing novel strategies to prevent severe AS.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol
    Moriyama, Kengo
    Takahashi, Eiko
    CLINICAL LABORATORY, 2017, 63 (7-8) : 1179 - 1186
  • [22] Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
    Arsenault, Benoit J.
    Loganath, Krithika
    Girard, Arnaud
    Botezatu, Simona
    Zheng, Kang H.
    Tzolos, Evangelos
    Abdoun, Kathia
    Tastet, Lionel
    Capoulade, Romain
    Cote, Nancy
    Craig, Neil
    Chan, Kwan L.
    Tam, James W.
    Teo, Koon K.
    Couture, Christian
    Clavel, Marie-Annick
    Mathieu, Patrick
    Theriault, Sebastien
    Stroes, Erik S. G.
    Newby, David E.
    Tsimikas, Sotirios
    Pibarot, Philippe
    Dweck, Marc R.
    JAMA CARDIOLOGY, 2024, 9 (09) : 835 - 842
  • [23] Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis
    Su, Xin
    Cai, Xueli
    Pan, Yuesong
    Sun, Jingping
    Jing, Jing
    Wang, Mengxing
    Meng, Xia
    Wang, Yongjun
    Wei, Tiemin
    He, Yan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (18) : 2349 - 2358
  • [24] Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
    Yeang, Calvin
    Karwatowska-Prokopczuk, Ewa
    Su, Fei
    Dinh, Brian
    Xia, Shuting
    Witztum, Joseph L.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (11) : 1035 - 1046
  • [25] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein, Apolipoprotein, or Low-Density Lipoprotein Particle What Should Clinicians Measure?
    Davidson, Michael H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2616 - 2617
  • [26] Association between monocyte to high-density lipoprotein cholesterol ratio and bicuspid aortic valve degeneration
    Karaduman, Bilge Duran
    Ayhan, Huseyin
    Keles, Telat
    Bozkurt, Engin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (05) : 1307 - 1313
  • [27] Role of Lipoprotein (A) in aortic valve stenosis: Novel disease mechanisms and emerging pharmacotherapeutic approaches☆
    Khan, Mohammad Ishrak
    Zahir, Raisa Subaita
    Dominguez, Abel Casso
    Romeo, Francisco Jose
    IJC HEART & VASCULATURE, 2024, 55
  • [28] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
  • [29] Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
    Burdeynaya, Anna L. L.
    Afanasieva, Olga I. I.
    Ezhov, Marat V. V.
    Klesareva, Elena A. A.
    Saidova, Marina A. A.
    Pokrovsky, Sergey N. N.
    DISEASES, 2023, 11 (01)
  • [30] Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
    Bourgeois, Raphaelle
    Devillers, Romain
    Perrot, Nicolas
    Despres, Audrey-Anne
    Boulanger, Marie-Chloe
    Mitchell, Patricia L.
    Guertin, Jakie
    Couture, Patrick
    Boffa, Michael B.
    Scipione, Corey A.
    Pibarot, Philippe
    Koschinsky, Marlys L.
    Mathieu, Patrick
    Arsenault, Benoit J.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2020, 5 (09): : 888 - 897